DOD Breast Cancer Research Program (BCRP) BA3/BA4/TBCC Awards – Pre-application
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: Inquire with unit
Memorial Deadline: RIS Review not required for pre-application
External Deadline: Friday 12th, June 2026
Description
Breakthrough Award Level 3
The intent of the FY26 BCRP Breakthrough Award is to support promising research with high
potential to lead to or make breakthroughs in breast cancer. This funding level supports advanced translational studies. Where relevant, the application must demonstrate proof of the availability of, and access to, necessary data, samples, cohort(s), and/or critical reagents for the proposed research.
Breakthrough Award Level 4
This funding level supports large-scale projects, including comparative effectiveness trials, that will transform and revolutionize the clinical management of and/or the prevention of breast cancer. This funding level requires clinical trials.
Transformative Breast Cancer Consortium Award
The intent of the FY26 BCRP Transformative Breast Cancer Consortium Award (TBCCA) is to
support collaborations and ideas that will transform the lives of individuals with, and/or at risk
for, breast cancer and will significantly accelerate progress toward ending breast cancer.
Applicants must bring together different perspectives to develop new paradigms that will solve
fundamental yet overarching problems in breast cancer. This award requires a team-based
approach with a consortium of exceptional researchers and breast cancer consumer advocates,
whose collaborative efforts will make a transformative impact in breast cancer. The consortium’s
intended transformation must occur in people’s lives, and not in the health care or research
system.
To view the BCRP funding opportunity announcements and submit a pre-application, visit https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=705101
Pre-Application Due: June 12, 2026
Application Due: September 30, 2026